Literature DB >> 9348370

Laparoscopic management of pelvic pathology during pregnancy.

S I Tazuke1, F R Nezhat, C H Nezhat, D S Seidman, D R Phillips, C R Nezhat.   

Abstract

Advanced operative laparoscopy is being performed increasingly for various indications and in diverse patient populations, including gravid women. In the United States approximately 1.6% to 2.2% of pregnant women require nonobstetric surgery for abdominal and pelvic pathology. Increasing numbers of case reports suggest the feasibility and safety of operative laparoscopy during pregnancy. We identified certain management issues specific to these procedures based on our experience with nine cases of operative laparoscopy in women with gestations up to 22 weeks.

Entities:  

Mesh:

Year:  1997        PMID: 9348370     DOI: 10.1016/s1074-3804(05)80097-0

Source DB:  PubMed          Journal:  J Am Assoc Gynecol Laparosc        ISSN: 1074-3804


  4 in total

1.  Guidelines for diagnosis, treatment, and use of laparoscopy for surgical problems during pregnancy: this statement was reviewed and approved by the Board of Governors of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), September 2007. It was prepared by the SAGES Guidelines Committee.

Authors:  Hori Yumi
Journal:  Surg Endosc       Date:  2008-02-21       Impact factor: 4.584

Review 2.  Diagnosis and laparoscopic treatment of surgical diseases during pregnancy: an evidence-based review.

Authors:  Heidi Jackson; Steven Granger; Raymond Price; Michael Rollins; David Earle; William Richardson; Robert Fanelli
Journal:  Surg Endosc       Date:  2008-06-14       Impact factor: 4.584

3.  Guidelines for diagnosis, treatment, and use of laparoscopy for surgical problems during pregnancy.

Authors:  Jonathan Pearl; Raymond Price; William Richardson; Robert Fanelli
Journal:  Surg Endosc       Date:  2011-09-23       Impact factor: 4.584

4.  Non-gynecologic laparoscopy in second and third trimester pregnancy: obstetric implications.

Authors:  J P Geisler; S L Rose; C S Mernitz; J L Warner; A K Hiett
Journal:  JSLS       Date:  1998 Jul-Sep       Impact factor: 2.172

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.